Patents by Inventor David H. Sierra

David H. Sierra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240125738
    Abstract: A method of making a sensor comprises depositing a plurality of surface-associated compositions on a piezoelectric base. The plurality of surface-associated compositions are adapted to stably associate with the piezoelectric base. The method further comprises depositing a plurality of crosslinking compositions on top of the surface-associated compositions. The crosslinking compositions are configured to bind to an analyte and crosslink one or more of the surface-associated compositions when the analyte binds to an analyte binding domain of a crosslinking composition and the surface-associated compositions include one or more polyclonal antibodies.
    Type: Application
    Filed: August 9, 2023
    Publication date: April 18, 2024
    Inventors: David H. Sierra, Andrew Korey
  • Patent number: 11740205
    Abstract: Sensors, as well as systems and methods of using the same are provided. Aspects of the sensors include a piezoelectric base, a plurality of surface-associated compositions that are stably associated with the piezoelectric base, and a plurality of crosslinking compositions that are configured to crosslink one or more surface-associated compositions in the presence of an analyte. The sensors, systems and methods described herein find use in a variety of applications, including the detection of an analyte in a sample.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: August 29, 2023
    Assignee: MODOC TECHNOLOGIES, LLC
    Inventors: David H. Sierra, Andrew Korey
  • Publication number: 20200348264
    Abstract: Sensors, as well as systems and methods of using the same are provided. Aspects of the sensors include a piezoelectric base, a plurality of surface-associated compositions that are stably associated with the piezoelectric base, and a plurality of crosslinking compositions that are configured to crosslink one or more surface-associated compositions in the presence of an analyte. The sensors, systems and methods described herein find use in a variety of applications, including the detection of an analyte in a sample.
    Type: Application
    Filed: April 15, 2020
    Publication date: November 5, 2020
    Inventors: David H. Sierra, Andrew Korey
  • Patent number: 10656123
    Abstract: Sensors, as well as systems and methods of using the same are provided. Aspects of the sensors include a piezoelectric base, a plurality of surface-associated compositions that are stably associated with the piezoelectric base, and a plurality of crosslinking compositions that are configured to crosslink one or more surface-associated compositions in the presence of an analyte. The sensors, systems and methods described herein find use in a variety of applications, including the detection of an analyte in a sample.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: May 19, 2020
    Assignee: Modoc Technologies, LLC
    Inventors: David H. Sierra, Andrew Korey
  • Publication number: 20180259488
    Abstract: Sensors, as well as systems and methods of using the same are provided. Aspects of the sensors include a piezoelectric base, a plurality of surface-associated compositions that are stably associated with the piezoelectric base, and a plurality of crosslinking compositions that are configured to crosslink one or more surface-associated compositions in the presence of an analyte. The sensors, systems and methods described herein find use in a variety of applications, including the detection of an analyte in a sample.
    Type: Application
    Filed: November 25, 2015
    Publication date: September 13, 2018
    Inventors: David H. Sierra, Andrew Korey
  • Patent number: 6280727
    Abstract: The present invention relates to thrombin-containing hemostatic compositions, their preparation and use. In particular, it relates to hemostatic compositions comprising stabilized thrombin and microfibrillar collagen in an aqueous medium. In a preferred embodiment of the present invention, the compositions are used in a kit comprising two different components, one of which is autologous patient's plasma as the source of fibrinogen, and the other of which is the thrombin-containing composition which also contains microfibrillar collagen.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: August 28, 2001
    Assignee: Cohesion Technologies, Inc.
    Inventors: Jeffrey J. Prior, Donald G. Wallace, David H. Sierra, Frank A. DeLustro
  • Patent number: 6277394
    Abstract: The current invention is a biomedical implant comprising a biomedical matrix material and a biodegradable porosifying agent. As the porosifying agent degrades in situ, an implant with an inter-connecting network is formed. The resultant mechanically stable implant allows for tissue and fluid influx into the matrix. The invention is also directed to a method for repair of mammalian tissue using the above-described implant.
    Type: Grant
    Filed: June 16, 2000
    Date of Patent: August 21, 2001
    Assignee: Cohesion Technologies, Inc.
    Inventor: David H. Sierra
  • Patent number: 6110484
    Abstract: The current invention is a biomedical implant comprising a biomedical matrix material and a biodegradable porosifying agent. As the porosifying agent degrades in situ, an implant with an inter-connecting network is formed. The resultant mechanically stable implant allows for tissue and fluid influx into the matrix. The invention is also directed to a method for repair of mammalian tissue using the above-described implant.
    Type: Grant
    Filed: November 24, 1998
    Date of Patent: August 29, 2000
    Assignee: Cohesion Technologies, Inc.
    Inventor: David H. Sierra
  • Patent number: 6096309
    Abstract: The present invention relates to thrombin-containing hemostatic compositions, their preparation and use. In particular, it relates to hemostatic compositions comprising stabilized thrombin and microfibrillar collagen in an aqueous medium. In a preferred embodiment of the present invention, the compositions are used in a kit comprising two different components, one of which is autologous patient's plasma as the source of fibrinogen, and the other of which is the thrombin-containing composition which also contains microfibrillar collagen having an average diameter of about 3-30 nanometers.
    Type: Grant
    Filed: June 17, 1998
    Date of Patent: August 1, 2000
    Assignee: Cohesion Technologies, Inc.
    Inventors: Jeffrey J. Prior, Donald G. Wallace, David H. Sierra, Frank A. DeLustro
  • Patent number: 5968018
    Abstract: A fluid separation device and in-line orifice mixer system is disclosed. The fluid separation device utilizes a syringe, which is used for obtaining a fluid sample such as blood, in a centrifugation device, and further utilizes the syringe as a source of a separated fluid portion for storage and transfer for subsequent applications. The syringe containing the separated portion source and a second syringe containing a second source are connected to the in-line orifice mixer device. The mixer device comprises a plurality of orifice walls each providing an orifice non-aligned with adjacent orifices to homogeneously mix the plurality of components. The mixer device may further comprise an exit orifice wall with one or more orifices for discharge of the homogeneous mixture.
    Type: Grant
    Filed: October 30, 1996
    Date of Patent: October 19, 1999
    Assignee: Cohesion Corporation
    Inventors: Abigail Freeman, Gerald G. Fuller, David H. Sierra, Stanley R. Conston, Alan S. Michaels
  • Patent number: 5290552
    Abstract: The present invention provides a surgical adhesive comprising, in an aqueous composition, fibrinogen, FXIII, collagen, thrombin, Ca.sup.2+ and optionally, an antifibrinolytic agent. The present adhesive may be formed from the patient's plasma without the use of any added reagents for concentration or isolation of the fibrinogen. Conveniently, the adhesive is formulated as a two-part composition which is mixed together just prior to use.
    Type: Grant
    Filed: March 23, 1992
    Date of Patent: March 1, 1994
    Assignee: Matrix Pharmaceutical, Inc./Project Hear
    Inventors: David H. Sierra, Edward E. Luck, Dennis M. Brown